i-Human Patients, Inc. (IHP) Company Profile

13:01 EST 18th December 2018 | BioPortfolio

i-Human Patients, Inc. (IHP) develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educators at more than 20 percent of U.S. medical schools are subscribing to or developing content on in anticipation of future use. Cloud-based and interactive, i-Human improves training outcomes and clinical protocol compliance for students, instructors, and practicing clinicians using active learning strategies and content developed by leading medical educators at more than 40 schools.

News Articles [851 Associated News Articles listed on BioPortfolio]

Promising Gene Therapy for Visually Impaired Sheep Now Safe for Human Trials

NewsBased on promising findings, the FDA has approved clinical trials for human patients and several U.S. medical centers have already begun using this therapy to treat patients with achromatopsia.

Human insulin as safe and effective as expensive insulin analogs for patients with type 2 diabetes

Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin, according...

CDC and Kognito utilize virtual human simulation to help breast cancer patients

To better educate triple negative breast cancer patients and ultimately improve health outcomes, the CDC Division of Cancer Prevention an

Human Pegivirus Identified in Encephalitis Patients

Human pegivirus (HPgV), was previously called hepatitis G virus or GB virus C, and is a lymphotropic virus with undefined...

Recombinant human pentraxin 2 slows the decline in lung function for patients with idiopathic pulmonary fibrosis

1. The use of recombinant human pentraxin 2 vs placebo resulted in a slower decline in lung function over 28 weeks for patients with idiopathic pulmonary fibrosis. 2. No significant treatment differen...

What Patients Really Want And Why Healthcare Companies Should Care

According to research by The Beryl Institute, patients are looking for healthcare providers to acknowledge their humanity and change the nature of the interactions involved in clinical encounters to m...

Would You Wear Human Leather with ‘Designer DNA’?

Artist Tina Gorjanc is working on a human leather collection that aims to highlight the shortcomings of laws that allow human biological material to be marketed without permission. Gorjanc has project...

Human medicines European public assessment report (EPAR): TachoSil, human fibrinogen / human thrombin, Revision: 22, Authorised

Drugs and Medications [0 Results]


PubMed Articles [5149 Associated PubMed Articles listed on BioPortfolio]

Human Papillomavirus And Human Cytomegalovirus Infection And Association With Prognosis In Primary Glioblastoma Patients Of Pakistan.

Glioblastoma (GBM) is the most common adult primary brain tumour. Human cytomegalovirus (HCMV) has been studied for the past decade and conflicting results have been reported with no conclusive role h...

Protection of patients' rights in the european court of human rights.

Introduction: Currently, there is little attention paid to studying the characteristic features of the protection of patients' rights in the European Court of Human Rights, which is the fact determini...

Presence of human herpes virus 1-thymidine kinase in testis of azoospermic infertile herpes-infected patients.

Infection with human herpes virus 1 (HHV1) is a suspected cause of human male infertility. However, the correlation between HHV1 infection and infertility is still unclear. We have previously generate...

Continued need for non-human primate neuroscience research.

Neuroscience research in non-human primates (NHPs) has delivered fundamental knowledge about human brain function as well as some valuable therapies that have improved the lives of human patients with...

Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.

Tuberculosis (TB) patients with human immunodeficiency virus (HIV) co-infection have worse TB treatment outcomes compared to patients with TB alone. The distribution of unfavourable treatment outcomes...

Clinical Trials [3199 Associated Clinical Trials listed on BioPortfolio]

Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

To compare the number of breakthrough bleeds under tailored prophylaxis with human cell line recombinant factor FVIII (Human-cl rhFVIII) with the historical bleeding rate from patients who...

The Tolerability,Safety,PK/PD Study of rhTPO in the Patients With Liver Function Impairment

The purpose of this study is to evaluate the tolerability, safety, pharmacokinetics and pharmacodynamics of recombinant human thrombopoietin in the patients with different degree of liver ...

Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology

A randomized, blinded, controlled trial to evaluate growth velocity and clinical outcomes in infants with single ventricle physiology fed an exclusive human milk diet prior to, and through...

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

RATIONALE: Vaccines made from certain human papillomaviruses may be able to help the body to kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of human papillomavi...

Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge

A GMP rhinovirus was manufactured according to GMP and then characterised in human volunteers in the human viral challenge model.

Companies [1897 Associated Companies listed on BioPortfolio]

i-Human Patients (IHP)

i-Human Patients, Inc. develops educational and competency assessment technology for the health care professional market, including its flagship i-Human Patients® platform, lau...

i-Human Patients, Inc.

i-Human Patients, Inc. develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educators at...

i-Human Patients, Inc. (IHP)

i-Human Patients, Inc. (IHP) develops virtual medical training products and services, including its flagship i-Human Patients® platform, launched in November 2012, which educat...

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc., a U.S. based, private monoclonal company, uses its biologic capabilities and its proprietary platform technology to develop first-in-class human an...

Acceptys, Inc.

Acceptys is a private biotechnology company focused on the development of human antibody therapies in cancer and infectious diseases. The Company's key strength is its ability to directly leverage the...

More Information about "i-Human Patients, Inc. (IHP)" on BioPortfolio

We have published hundreds of i-Human Patients, Inc. (IHP) news stories on BioPortfolio along with dozens of i-Human Patients, Inc. (IHP) Clinical Trials and PubMed Articles about i-Human Patients, Inc. (IHP) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of i-Human Patients, Inc. (IHP) Companies in our database. You can also find out about relevant i-Human Patients, Inc. (IHP) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record